A simultaneous determination of anti-cancer drugs in hospital effluent by DLLME HPLC-FLD, together with a risk assessment.
Currently, there is an increasing use of anti-cancer drugs, and hence their occurrence in the environment must be properly managed, in particular, in the light of their high degree of toxicity. In this study, analytical methods using HPLC-FLD assisted by microextraction and solid phase extraction, were developed and validated for the determination of doxorubicin, daunorubicin, epirubicin and irinotecan in hospital effluent. The validation results show determination coefficients (r2) higher than 0.99 and recovery values between 74% and 105%, with an intraday precision of <15%.The limit of quantification was 1.0 μg L- 1 and there were almost no matrix effects. The methods proposed were employed for the determination of the named chemotherapeutics in effluent samples of the University Hospital of Santa Maria, Brazil and quantified in the range of ≥LOQ ̶ 6.22 μg L-1. A preliminary ecotoxicological risk assessment showed values that were potentially very harmful, and thus, the treatment of the hospital effluents requires special attention.